Stryker Pre-Tax Profit Margin 2012-2025 | SYK
Current and historical pre-tax profit margin for Stryker (SYK) from 2012 to 2025. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. Stryker pre-tax profit margin for the three months ending December 31, 2025 was .
| Stryker Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2025-12-31 | $25.12B | $4.51B | 17.97% |
| 2025-09-30 | $24.38B | $3.34B | 13.69% |
| 2025-06-30 | $23.82B | $3.35B | 14.07% |
| 2025-03-31 | $23.22B | $3.33B | 14.36% |
| 2024-12-31 | $22.60B | $3.49B | 15.45% |
| 2024-09-30 | $21.97B | $4.19B | 19.07% |
| 2024-06-30 | $21.39B | $4.02B | 18.78% |
| 2024-03-31 | $20.96B | $3.92B | 18.69% |
| 2023-12-31 | $20.50B | $3.67B | 17.92% |
| 2023-09-30 | $19.89B | $3.21B | 16.13% |
| 2023-06-30 | $19.46B | $3.16B | 16.22% |
| 2023-03-31 | $18.95B | $2.98B | 15.70% |
| 2022-12-31 | $18.45B | $2.68B | 14.54% |
| 2022-09-30 | $17.95B | $2.68B | 14.93% |
| 2022-06-30 | $17.63B | $2.36B | 13.38% |
| 2022-03-31 | $17.43B | $2.30B | 13.20% |
| 2021-12-31 | $17.11B | $2.28B | 13.33% |
| 2021-09-30 | $16.67B | $2.20B | 13.17% |
| 2021-06-30 | $16.25B | $2.48B | 15.27% |
| 2021-03-31 | $14.72B | $1.73B | 11.76% |
| 2020-12-31 | $14.35B | $1.95B | 13.62% |
| 2020-09-30 | $14.22B | $2.22B | 15.60% |
| 2020-06-30 | $14.07B | $2.02B | 14.36% |
| 2020-03-31 | $14.96B | $2.67B | 17.87% |
| 2019-12-31 | $14.88B | $2.56B | 17.21% |
| 2019-09-30 | $14.55B | $2.28B | 15.69% |
| 2019-06-30 | $14.20B | $2.24B | 15.74% |
| 2019-03-31 | $13.88B | $2.29B | 16.53% |
| 2018-12-31 | $13.60B | $2.36B | 17.32% |
| 2018-09-30 | $13.28B | $2.35B | 17.69% |
| 2018-06-30 | $13.04B | $2.29B | 17.52% |
| 2018-03-31 | $12.73B | $2.11B | 16.54% |
| 2017-12-31 | $12.44B | $2.06B | 16.58% |
| 2017-09-30 | $12.13B | $2.00B | 16.50% |
| 2017-06-30 | $11.96B | $1.95B | 16.31% |
| 2017-03-31 | $11.79B | $1.94B | 16.45% |
| 2016-12-31 | $11.33B | $1.92B | 16.96% |
| 2016-09-30 | $10.88B | $1.95B | 17.87% |
| 2016-06-30 | $10.47B | $1.87B | 17.87% |
| 2016-03-31 | $10.06B | $1.84B | 18.28% |
| 2015-12-31 | $9.95B | $1.74B | 17.44% |
| 2015-09-30 | $9.85B | $1.58B | 16.08% |
| 2015-06-30 | $9.82B | $1.66B | 16.95% |
| 2015-03-31 | $9.75B | $1.43B | 14.67% |
| 2014-12-31 | $9.68B | $1.16B | 11.99% |
| 2014-09-30 | $9.53B | $1.13B | 11.86% |
| 2014-06-30 | $9.29B | $0.84B | 9.07% |
| 2014-03-31 | $9.14B | $0.94B | 10.33% |
| 2013-12-31 | $9.02B | $1.21B | 13.44% |
| 2013-09-30 | $8.89B | $1.14B | 12.81% |
| 2013-06-30 | $8.79B | $1.45B | 16.45% |
| 2013-03-31 | $8.69B | $1.61B | 18.56% |
| 2012-12-31 | $8.66B | $1.71B | 19.70% |
| 2012-09-30 | $8.53B | $1.78B | 20.86% |
| 2012-06-30 | $8.51B | $1.77B | 20.76% |
| 2012-03-31 | $8.45B | $1.74B | 20.62% |
| 2011-12-31 | $8.31B | $1.69B | 20.30% |
| 2011-09-30 | $8.09B | $1.63B | 20.18% |
| 2011-06-30 | $7.82B | $1.66B | 21.26% |
| 2011-03-31 | $7.54B | $1.70B | 22.49% |
| 2010-12-31 | $7.32B | $1.73B | 23.63% |
| 2010-09-30 | $7.16B | $1.87B | 26.18% |
| 2010-06-30 | $7.04B | $1.73B | 24.50% |
| 2010-03-31 | $6.92B | $1.68B | 24.32% |
| 2009-12-31 | $6.72B | $1.62B | 24.14% |
| 2009-09-30 | $6.61B | $1.48B | 22.40% |
| 2009-06-30 | $6.61B | $1.54B | 23.34% |
| 2009-03-31 | $6.69B | $1.56B | 23.37% |
| 2008-12-31 | $6.72B | $1.58B | 23.52% |
| 2008-09-30 | $6.66B | $1.58B | 23.79% |
| 2008-06-30 | $6.46B | $1.53B | 23.63% |
| 2008-03-31 | $6.21B | $1.44B | 23.16% |
| 2007-12-31 | $6.00B | $1.37B | 22.83% |
| 2007-09-30 | $5.68B | $1.30B | 22.89% |
| 2007-06-30 | $5.45B | $1.24B | 22.75% |
| 2007-03-31 | $5.25B | $1.20B | 22.91% |
| 2006-12-31 | $5.15B | $1.09B | 21.26% |
| 2006-09-30 | $4.83B | $1.02B | 21.06% |
| 2006-06-30 | $4.77B | $0.97B | 20.35% |
| 2006-03-31 | $4.73B | $0.93B | 19.63% |
| 2005-12-31 | $4.61B | $0.94B | 20.33% |
| 2005-09-30 | $4.75B | $0.89B | 18.82% |
| 2005-06-30 | $4.61B | $0.75B | 16.32% |
| 2005-03-31 | $4.43B | $0.72B | 16.23% |
| 2004-12-31 | $4.26B | $0.68B | 15.88% |
| 2004-09-30 | $4.11B | $0.68B | 16.48% |
| 2004-06-30 | $3.96B | $0.76B | 19.12% |
| 2004-03-31 | $3.81B | $0.70B | 18.25% |
| 2003-12-31 | $3.63B | $0.65B | 18.01% |
| 2003-09-30 | $3.45B | $0.61B | 17.64% |
| 2003-06-30 | $3.31B | $0.56B | 17.02% |
| 2003-03-31 | $3.16B | $0.54B | 16.98% |
| 2002-12-31 | $3.01B | $0.51B | 16.80% |
| 2002-09-30 | $2.89B | $0.48B | 16.56% |
| 2002-06-30 | $2.77B | $0.46B | 16.67% |
| 2002-03-31 | $2.67B | $0.43B | 16.14% |
| 2001-12-31 | $2.60B | $0.41B | 15.60% |
| 2001-09-30 | $2.50B | $0.39B | 15.38% |
| 2001-06-30 | $2.43B | $0.37B | 15.25% |
| 2001-03-31 | $2.36B | $0.35B | 14.95% |
| 2000-12-31 | $2.29B | $0.34B | 14.68% |
| 2000-09-30 | $2.24B | $0.30B | 13.51% |
| 2000-06-30 | $2.19B | $0.23B | 10.33% |
| 2000-03-31 | $2.14B | $0.14B | 6.53% |
| 1999-12-31 | $2.10B | $0.03B | 1.38% |
| 1999-09-30 | $1.87B | $-0.14B | -7.56% |
| 1999-06-30 | $1.63B | $-0.09B | -5.41% |
| 1999-03-31 | $1.37B | $-0.03B | -2.04% |
| 1998-12-31 | $1.10B | $0.06B | 5.35% |
| 1998-09-30 | $1.04B | $0.22B | 20.85% |
| 1998-06-30 | $1.01B | $0.21B | 20.53% |
| 1998-03-31 | $0.99B | $0.20B | 20.22% |
| 1997-12-31 | $0.98B | $0.19B | 19.80% |
| 1997-09-30 | $0.97B | $0.18B | 18.47% |
| 1997-06-30 | $0.96B | $0.17B | 18.12% |
| 1997-03-31 | $0.93B | $0.17B | 17.92% |
| 1996-12-31 | $0.91B | $0.16B | 17.69% |
| 1996-09-30 | $0.89B | $0.17B | 18.63% |
| 1996-06-30 | $0.87B | $0.16B | 18.69% |
| 1996-03-31 | $0.88B | $0.16B | 18.49% |
| 1995-12-31 | $0.87B | $0.16B | 18.69% |
| 1995-09-30 | $0.85B | $0.16B | 18.87% |
| 1995-06-30 | $0.82B | $0.16B | 18.86% |
| 1995-03-31 | $0.75B | $0.14B | 19.01% |
| 1994-12-31 | $0.68B | $0.13B | 18.62% |
| 1994-09-30 | $0.62B | $0.11B | 18.17% |
| 1994-06-30 | $0.59B | $0.11B | 18.12% |
| 1994-03-31 | $0.57B | $0.10B | 17.86% |
| 1993-12-31 | $0.56B | $0.10B | 17.41% |
| 1993-09-30 | $0.54B | $0.09B | 17.16% |
| 1993-06-30 | $0.52B | $0.09B | 16.86% |
| 1993-03-31 | $0.50B | $0.08B | 16.63% |
| 1992-12-31 | $0.48B | $0.08B | 16.35% |
| 1992-09-30 | $0.45B | $0.07B | 15.85% |
| 1992-06-30 | $0.42B | $0.07B | 15.44% |
| 1992-03-31 | $0.39B | $0.06B | 15.01% |
| 1991-12-31 | $0.37B | $0.05B | 14.75% |
| 1991-09-30 | $0.34B | $0.05B | 13.70% |
| 1991-06-30 | $0.32B | $0.04B | 13.71% |
| 1991-03-31 | $0.30B | $0.04B | 13.67% |
| 1990-12-31 | $0.28B | $0.04B | 13.48% |
| 1990-09-30 | $0.26B | $0.04B | 13.64% |
| 1990-06-30 | $0.25B | $0.04B | 13.94% |
| 1990-03-31 | $0.24B | $0.03B | 13.75% |
| 1989-12-31 | $0.23B | $0.03B | 13.72% |
| 1989-09-30 | $0.21B | $0.03B | 13.55% |
| 1989-06-30 | $0.20B | $0.03B | 13.30% |
| 1989-03-31 | $0.19B | $0.03B | 13.68% |
| 1988-12-31 | $0.18B | $0.03B | 13.97% |
| 1988-09-30 | $0.17B | $0.02B | 14.29% |
| 1988-06-30 | $0.16B | $0.02B | 14.91% |
| 1988-03-31 | $0.15B | $0.02B | 14.94% |
| 1987-12-31 | $0.15B | $0.02B | 14.86% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $140.083B | $25.116B |
| Stryker Corporation is a medical device company operating in the global orthopedic market. The company has three business segments: Orthopaedics, MedSurg and Neurotechnology & Spine. Orthopaedic?products include implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg?products consists of surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment and reprocessed and remanufactured medical devices. Neurotechnology & Spine division includes both neurosurgical and neurovascular devices. These includes products used for minimally invasive endovascular techniques; traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. Spinal implant product offering includes cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $195.936B | 21.88 |
| EssilorLuxottica (ESLOY) | France | $142.091B | 0.00 |
| Medtronic (MDT) | Ireland | $127.548B | 17.67 |
| Boston Scientific (BSX) | United States | $110.783B | 24.50 |
| Medline (MDLN) | United States | $58.526B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.093B | 0.00 |
| ResMed (RMD) | United States | $36.791B | 24.57 |
| GE HealthCare Technologies (GEHC) | United States | $36.615B | 17.54 |
| Agilent Technologies (A) | United States | $35.584B | 22.55 |
| Koninklijke Philips (PHG) | Netherlands | $30.091B | 17.86 |
| Terumo (TRUMY) | Japan | $21.610B | 25.26 |
| Zimmer Biomet Holdings (ZBH) | United States | $19.115B | 11.76 |
| Insulet (PODD) | United States | $17.076B | 53.00 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $15.372B | 0.00 |
| Baxter (BAX) | United States | $10.182B | 8.72 |
| Sunny Optical Technology (SNPTF) | China | $8.485B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.921B | 25.86 |
| Demant (WILYY) | Denmark | $6.042B | 0.00 |
| Envista Holdings (NVST) | United States | $4.747B | 24.14 |
| Lantheus Holdings (LNTH) | United States | $4.601B | 14.02 |
| BillionToOne (BLLN) | United States | $4.056B | 0.00 |
| ICU Medical (ICUI) | United States | $3.577B | 22.71 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.263B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.160B | 14.91 |
| Haemonetics (HAE) | United States | $2.684B | 11.74 |
| Neogen (NEOG) | United States | $2.380B | 52.10 |
| Phibro Animal Health (PAHC) | United States | $2.118B | 18.66 |
| Perrigo (PRGO) | Ireland | $2.001B | 5.01 |
| LeMaitre Vascular (LMAT) | United States | $1.989B | 40.03 |
| Curaleaf Holdings (CURLF) | Canada | $1.642B | 0.00 |
| AtriCure (ATRC) | United States | $1.623B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.602B | 11.12 |
| Kestra Medical Technologies (KMTS) | United States | $1.571B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.446B | 63.36 |
| AdaptHealth (AHCO) | United States | $1.381B | 20.00 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.358B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.070B | 317.57 |
| Capricor Therapeutics (CAPR) | United States | $1.026B | 0.00 |
| InMode (INMD) | Israel | $0.906B | 9.93 |
| Tilray Brands (TLRY) | Canada | $0.875B | 0.00 |
| Valneva SE (VALN) | France | $0.868B | 0.00 |
| Omeros (OMER) | United States | $0.829B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.757B | 0.00 |
| CeriBell (CBLL) | United States | $0.733B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.566B | 13.52 |
| Brainsway (BWAY) | Israel | $0.451B | 76.63 |
| Canopy Growth (CGC) | Canada | $0.436B | 0.00 |
| Cerus (CERS) | United States | $0.430B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.396B | 0.00 |
| SNDL (SNDL) | Canada | $0.386B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.361B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.328B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.315B | 25.09 |
| Evolus (EOLS) | United States | $0.279B | 0.00 |
| Quanterix (QTRX) | United States | $0.268B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.243B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Sanuwave Health (SNWV) | United States | $0.213B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.205B | 18.42 |
| High Tide (HITI) | Canada | $0.203B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.201B | 59.17 |
| OraSure Technologies (OSUR) | United States | $0.197B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.182B | 0.00 |
| Organigram Global (OGI) | Canada | $0.174B | 0.00 |
| Accendra Health (ACH) | United States | $0.173B | 1.74 |
| Vireo Growth (VREOF) | United States | $0.170B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.168B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Apyx Medical (APYX) | United States | $0.142B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.134B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.129B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.42 |
| MacroGenics (MGNX) | United States | $0.108B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.100B | 0.00 |
| Biote (BTMD) | United States | $0.097B | 4.26 |
| Exagen (XGN) | United States | $0.074B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 25.39 |
| Sharps Technology (STSS) | United States | $0.051B | 0.00 |
| Nephros (NEPH) | United States | $0.044B | 31.54 |
| Cytosorbents (CTSO) | United States | $0.040B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.040B | 0.00 |
| Veru (VERU) | United States | $0.037B | 0.00 |
| Modular Medical (MODD) | United States | $0.035B | 0.00 |
| United-Guardian (UG) | United States | $0.030B | 15.35 |
| Jin Medical (ZJYL) | China | $0.022B | 0.00 |
| Bonk (BNKK) | United States | $0.021B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.014B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| INLIF (INLF) | China | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Agape ATP (ATPC) | $0.002B | 0.00 | |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |